Multinational pharmaceutical and biotech company Bayer will outsource the distribution of its pharmaceutical and consumer health products in East and Anglo-West Africa, beginning May 1.
- It will outsource transportation, local warehousing, distribution, and customer support to a third party.
- Bayer will continue to handle business-related corporate affairs including medical affairs, media relations, and stakeholder relations.
- According to the company, the new approach is intended to simplify its value chain, reduce lead time between production and distribution and hence reach more patients and customers, ultimately increasing its footprint.
“We are calling this initiative ‘Smart Serve’, as it is intended to help reach and serve more people in Africa in a more sustainable manner,” Jorge Levinson, Cluster Lead for the Pharmaceuticals Division in South East and West Central Africa, said, “We shall be leveraging the expertise and networks of a third-party distributor to ensure sustained availability and access of our products and solutions.”
“We do not underestimate the possible disruption, and we aim to minimize its effects where possible, remaining committed to always treat everyone with respect, dignity, and care,” Michael Meewes, Cluster Lead for the Consumer Health in South East West Africa added.
Bayer completes acquisition of Monsanto – Kenyan Wallstreet
